Publicacions en què col·labora amb P. Zamora Auñon (10)

1997

  1. Experience of oncopaz cooperative group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast

    Oncology (Switzerland), Vol. 54, Núm. 1, pp. 30-37

1996

  1. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

    Cancer, Vol. 78, Núm. 2, pp. 211-216

1995

  1. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

    European Journal of Cancer, Vol. 31, Núm. 13-14, pp. 2215-2219

  2. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ cooperative group

    Cancer Chemotherapy and Pharmacology, Vol. 36, Núm. 3, pp. 255-258

1994

  1. Comparison of two chemotherapeutic regimens - mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) - in advanced non-small-cell lung cancer

    Annals of Oncology, Vol. 5, Núm. 4, pp. 323-327

1992

  1. Autoimmune hemolytic anemia and carcinoma of the larynx: an exceptional association

    Revista clínica española, Vol. 191, Núm. 4, pp. 207-208

  2. Non-small-cell lung cancer (NSCLC): Chemotherapy in advanced disease. Our experience in ten years

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 15, Núm. 1, pp. 23-28

  3. Usefulness of megestrol acetate in cancer cachexia and anorexia: A placebo-controlled study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 15, Núm. 5, pp. 436-440

1991

  1. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy: A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam

    Acta Oncologica, Vol. 30, Núm. 5, pp. 623-627

1990

  1. Phase II trial of cisplatin and tegafur (Ftorafur) as initial therapy in squamous-cell carcinoma of the head and neck

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 13, Núm. 4, pp. 312-314